| ASD-only (N = 44) | ASD + E (N = 22) | p value |
---|---|---|---|
Agea (years) | 8.273 ± 4.326 | 10.227 ± 5.814 | 0.172 |
Genderb | |||
 Male | 43 (97.7 %) | 21 (95.5 %) | >0.999 |
 Female | 1 (2.3 %) | 1 (4.5 %) | |
FSIQa | 62.318 ± 17.095 | 55.455 ± 18.397 | 0.139 |
VIQa | 67.80 ± 22.130 | 58.68 ± 21.007 | 0.114 |
PIQa | 62.73 ± 15.813 | 58.27 ± 16.799 | 0.295 |
Intellectual disability based on FSIQb | |||
 Non-intellectual disability IQ >70 | 12 (27.3 %) | 5 (22.7 %) | 0.102 |
 Mild intellectual disability IQ 50–70 | 20 (45.5 %) | 6 (27.3 %) | |
 Moderate-severe intellectual disability IQ <50 | 12 (27.3 %) | 11 (50.0 %) | |
Gestation age (weeks)b | |||
 ≤31 | 1 (2.3 %) | 0 (0 %) | 0.386 |
 32–36 | 8 (18.2 %) | 2 (9.1 %) | |
 37–41 | 35 (79.5 %) | 54 (81.8 %) | |
 ≥42 | 0 (0 %) | 1 (4.5 %) | |
Birth weight (g)b | |||
 1500–2499 | 2 (4.5 %) | 1 (4.5 %) | 0.072 |
 2500–3999 | 41 (93.2 %) | 17 (77.3 %) | |
 4000–4499 | 1 (2.3 %) | 4 (18.2 %) | |
Obstetrics complicationb | |||
 No | 38 (86.4 %) | 17 (77.3 %) | 0.485 |
 Yes | 6 (13.6 %) | 5 (22.7 %) | |
Antipsychotic medicationb | |||
 No | 25 (56.8 %) | 8 (36.4 %) | 0.191 |
 Yes | 19 (43.2 %) | 14 (63.6 %) |